ATMP Lunch Webinar: Understanding ATMP Approval
On Thursday 10 September 2026, from 12:00 to 13:00, the Danish pharmaceutical industry association Lif holds an online lunch webinar on the approval of advanced therapy medicinal products. The session looks at how regulators assess ATMPs, and how that differs from conventional medicines.
Martin B. Oleksiewicz, Senior Advisor at the Danish Medicines Agency and Denmark’s member of the EMA Committee for Advanced Therapies, opens with the regulatory perspective. Lucas Andre Dirson, Global Program Regulatory Associate Director at Novartis, then gives the industry view. A question and discussion session closes the hour.
The webinar runs in English and costs nothing to attend. It is the second in a series Lif runs through 2026 on the industry contribution to ATMPs. Registration closes on 7 September 2026. Sign up for the webinar here.
